In contrast, complement-3 (C3) levels, an inflammatory protein with antifibrinolytic properties, were lower in the MODY group compared with T2DM (0.58 ± 0.09 vs 0.80 ± 0.1, p < 0.01; Figure 1(b)). Here, C3 is linked to type 2 diabetes mellitus.